SPOP has been reported to suppress tumorigenesis by inhibiting the NF-κB pathway in certain tumor types [109,110], indicating that this SPOP‒FADD‒NF-κB axis might represent a molecular mechanism underlying the role of FADD alteration in non-small-cell lung cancer [109]. The gene discussed is FADD; the disease is neoplasm.